Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an oral immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis.

Employee Rating

3.3More
TypePublic
HQParis, FR
Founded2004
Size (employees)106,566 (est)
Websiteen.sanofi.com
Sanofi was founded in 2004 and is headquartered in Paris, FR
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Sanofi

Olivier Brandicourt

Olivier Brandicourt

CEO
Olivier Charmeil

Olivier Charmeil

Executive Vice President and General Manager
Jerome Contamine

Jerome Contamine

Executive Vice President & Chief Financial Officer
Karen Linehan

Karen Linehan

Executive Vice President, Legal Affairs and General Counsel
David Loew

David Loew

Executive Vice President and General Manager of Sanofi Pasteur
Philippe Luscan

Philippe Luscan

Executive Vice President, Global Industrial Affairs
Show more

Sanofi Office Locations

Sanofi has offices in Paris, Singapore, Séoul, Ontario and in 9 other locations
Paris, FR (HQ)
54, rue La Boétie
Macquarie Park, AU
Building D, 12-24 Talavera Road
Ontario, CA
1755 Steeles avenue West
Beijing, CN
7th floor, n°112, Jian Guo Lu, Chaoyang District
Hong Kong, HK
Room 2504-2511, Windsor House, 311, Gloucester Road, Causeway Bay
New Delhi, IN
D-2, Fourth Floor, Southern Park, DDA Commercial Centre, Saket
Show all (13)
Report incorrect company information

Sanofi Financials and Metrics

Sanofi Revenue

Embed Graph
View revenue for all periods
Sanofi's revenue was reported to be €37.06 b in FY, 2015 which is a 9.7% increase from the previous period.
EUR

Revenue (FY, 2015)

37.1b

Revenue growth (FY, 2014 - FY, 2015), %

9.7%

Gross profit (FY, 2015)

26.1b

Gross profit margin (FY, 2015), %

70.5%

Net income (FY, 2015)

4.4b
EURFY, 2013FY, 2014FY, 2015

Revenue

33.0b33.8b37.1b

Revenue growth, %

2%10%

Cost of goods sold

10.3b10.2b10.9b

Gross profit

22.6b23.5b26.1b
EURFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

6.4b6.3b7.2b
EURY, 2015

Revenue/Employee

365.4k
Show all financial metrics

Sanofi Operating Metrics

Y, 2013Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA

1

Phase III Trials Products

11 9 8 7

Projects in R&D Pipeline

36 32 34 43
Show all operating metrics

Sanofi Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Ablynx January 29, 2018$4.80 b
Bioverativ January 22, 2018$11.60 b

Sanofi Revenue Breakdown

Embed Graph

Sanofi revenue breakdown by business segment: 80.4% from Pharmaceuticals, 12.8% from Vaccines and 6.8% from Animal Health

Report incorrect company information

Sanofi Online and Social Media Presence

Embed Graph
Report incorrect company information

Sanofi Company Life and Culture

Report incorrect company information

Sanofi Frequently Asked Questions

  • When was Sanofi founded?

    Sanofi was founded in 2004.

  • Who are Sanofi key executives?

    Sanofi's key executives are Olivier Brandicourt, Olivier Charmeil and Jerome Contamine.

  • How many employees does Sanofi have?

    Sanofi has 106,566 employees.

  • What is Sanofi revenue?

    Latest Sanofi annual revenue is €37.1 b.

  • What is Sanofi revenue per employee?

    Latest Sanofi revenue per employee is €347.7 k.

  • Who are Sanofi competitors?

    Competitors of Sanofi include Regeneron Pharmaceuticals, Celgene and Immunicum .

  • Where is Sanofi headquarters?

    Sanofi headquarters is located at 54, rue La Boétie, Paris.

  • Where are Sanofi offices?

    Sanofi has offices in Paris, Singapore, Séoul, Ontario and in 9 other locations.

  • How many offices does Sanofi have?

    Sanofi has 13 offices.